Clinical trial
An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications.
NCT02678676 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications.
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2004
- Completion date
- November 30, 2011
- Enrollment
- 3,599 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.